Urotensin II in Chronic Kidney Diseases and Kidney Transplants

NCT01098799 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2013-06-13

No results posted yet for this study

Summary

The investigators are planning to study the serum level of Urotensin II in chronic kidney disease patients, kidney transplants, and healthy controls.

Conditions

  • Chronic Renal Disease

Sponsors & Collaborators

  • Vakif Gureba Training and Research Hospital

    lead OTHER

Principal Investigators

  • Tufan Tukek, MD · Vakif Gureba Training & Research Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01098799 on ClinicalTrials.gov